Q: What are the active ingredients in Verzenio?

The active ingredient in Verzenio is abemaciclib .

Q: What are the side effects of Verzenio?

Common side effects of Verzenio may include: diarrhea fatigue nausea and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Verzenio?

Verzenio belongs to the CDK4/6 inhibitor drug class.

Q: What is the dosage of Verzenio and how do I take it?

How to Take Verzenio Verzenio is taken by mouth as a tablet. It is usually prescribed to be taken twice a day. To help you remember your doses, try to take the medication at the same time every morning and evening. Administration Instructions Swallow whole: Tablets should be swallowed whole. Do not crush, chew, or break the tablets before swallowing. Do not take any tablet that is broken, cracked, or otherwise damaged. Food and drink: You may take Verzenio with or without food. However, you should avoid grapefruit and grapefruit juice while being treated with this medication, as these products can change how the drug is processed by your body. Missed or Vomited Doses If you miss a dose, skip that dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed one. If you vomit after taking a dose of Verzenio, do not take an additional dose to replace it. Simply wait and take your next scheduled dose at the usual time. Storage and Handling Keep the medication in its original container, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat or moisture.

Q: Is Verzenio safe during pregnancy and breastfeeding?

Pregnancy Verzenio can cause harm to a developing fetus. Healthcare providers typically require a pregnancy test before starting this medication to confirm that a patient is not pregnant. For individuals who are able to become pregnant: Use effective birth control (contraception) during treatment and for at least 3 weeks after the final dose. Inform a healthcare provider immediately if you become pregnant or think you might be pregnant while taking this medication. Breastfeeding It is not known if Verzenio passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 3 weeks after the last dose. Fertility Verzenio may impair fertility in males, which may affect the ability to father a child. Patients should discuss any concerns regarding reproductive health and fertility with their healthcare provider before beginning treatment.

Q: What is the FDA approval status of Verzenio?

FDA Approval Status Verzenio was initially approved by the U.S. Food and Drug Administration (FDA) in September 2017. It is classified as a kinase inhibitor and is used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. Approved Indications The FDA has granted approval for Verzenio in several clinical settings: Early Breast Cancer: In combination with endocrine therapy for the treatment of patients with node-positive, early breast cancer at high risk of recurrence. Advanced or Metastatic Cancer: In combination with an aromatase inhibitor as the first endocrine-based therapy for postmenopausal women or men. Combination Therapy: In combination with fulvestrant for patients whose disease has progressed following endocrine therapy. Monotherapy: As a stand-alone treatment for patients with metastatic disease that has progressed after endocrine therapy and prior chemotherapy. Regulatory Safety Communications The FDA issued a safety communication in 2019 regarding the class of CDK4/6 inhibitors, which includes Verzenio. This warning concerns the rare but serious risk of interstitial lung disease (ILD) and pneumonitis, which is inflammation of the lungs. Healthcare providers are advised to monitor patients for pulmonary symptoms and to interrupt or discontinue treatment if severe lung inflammation occurs. Verzenio does not currently have a Boxed Warning or a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 1

What is Verzenio?

Accepted Answer

Verzenio belongs to a class of drugs called kinase inhibitors. It works by interfering with the activity of specific proteins that signal cancer cells to multiply, which helps to slow or stop the progression of the disease.

This medication is designed to target the biological processes that allow cancer cells to spread. By inhibiting these pathways, it helps control the growth of cancer within the body.

Question 2

What is Verzenio used for?

Accepted Answer

Verzenio is used to treat breast cancer.

Question 3

How does Verzenio work?

Accepted Answer

Verzenio belongs to a class of medications called kinase inhibitors. Specifically, it is known as a CDK4/6 inhibitor. It works by targeting and blocking the activity of two proteins in the body:

Cyclin-dependent kinase 4 (CDK4)
Cyclin-dependent kinase 6 (CDK6)

These proteins play a critical role in the cell cycle, which is the process cells go through to grow and divide. In certain types of breast cancer, these proteins become overactive, causing cancer cells to multiply uncontrollably.

By inhibiting CDK4 and CDK6, Verzenio stops the cancer cells from progressing through the cell cycle. This prevents the cells from dividing and creating new cancer cells, which can help shrink tumors or slow the spread of the disease.

Question 4

What are the active ingredients in Verzenio?

Accepted Answer

The active ingredient in Verzenio is abemaciclib.

Question 5

What are the side effects of Verzenio?

Accepted Answer

Common side effects of Verzenio may include:

diarrhea
fatigue
nausea
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Verzenio?

Accepted Answer

Verzenio belongs to the CDK4/6 inhibitor drug class.

Question 7

What is the dosage of Verzenio and how do I take it?

Accepted Answer

How to Take Verzenio

Verzenio is taken by mouth as a tablet. It is usually prescribed to be taken twice a day. To help you remember your doses, try to take the medication at the same time every morning and evening.

Administration Instructions

Swallow whole: Tablets should be swallowed whole. Do not crush, chew, or break the tablets before swallowing. Do not take any tablet that is broken, cracked, or otherwise damaged.
Food and drink: You may take Verzenio with or without food. However, you should avoid grapefruit and grapefruit juice while being treated with this medication, as these products can change how the drug is processed by your body.

Missed or Vomited Doses

If you miss a dose, skip that dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed one.

If you vomit after taking a dose of Verzenio, do not take an additional dose to replace it. Simply wait and take your next scheduled dose at the usual time.

Storage and Handling

Keep the medication in its original container, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat or moisture.

Question 8

Is Verzenio safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Verzenio can cause harm to a developing fetus. Healthcare providers typically require a pregnancy test before starting this medication to confirm that a patient is not pregnant.

For individuals who are able to become pregnant:

Use effective birth control (contraception) during treatment and for at least 3 weeks after the final dose.
Inform a healthcare provider immediately if you become pregnant or think you might be pregnant while taking this medication.

Breastfeeding

It is not known if Verzenio passes into human breast milk. Due to the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 3 weeks after the last dose.

Fertility

Verzenio may impair fertility in males, which may affect the ability to father a child. Patients should discuss any concerns regarding reproductive health and fertility with their healthcare provider before beginning treatment.

Question 9

What forms and strengths does Verzenio come in?

Accepted Answer

Verzenio is supplied as a film-coated tablet intended for oral administration. These tablets should be swallowed whole and not crushed, chewed, or broken.

Question 10

What is the FDA approval status of Verzenio?

Accepted Answer

FDA Approval Status

Verzenio was initially approved by the U.S. Food and Drug Administration (FDA) in September 2017. It is classified as a kinase inhibitor and is used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

Approved Indications

The FDA has granted approval for Verzenio in several clinical settings:

Early Breast Cancer: In combination with endocrine therapy for the treatment of patients with node-positive, early breast cancer at high risk of recurrence.
Advanced or Metastatic Cancer: In combination with an aromatase inhibitor as the first endocrine-based therapy for postmenopausal women or men.
Combination Therapy: In combination with fulvestrant for patients whose disease has progressed following endocrine therapy.
Monotherapy: As a stand-alone treatment for patients with metastatic disease that has progressed after endocrine therapy and prior chemotherapy.

Regulatory Safety Communications

The FDA issued a safety communication in 2019 regarding the class of CDK4/6 inhibitors, which includes Verzenio. This warning concerns the rare but serious risk of interstitial lung disease (ILD) and pneumonitis, which is inflammation of the lungs. Healthcare providers are advised to monitor patients for pulmonary symptoms and to interrupt or discontinue treatment if severe lung inflammation occurs.

Verzenio does not currently have a Boxed Warning or a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 11

What should I know about Verzenio and cost?

Accepted Answer

Insurance and Pharmacy Factors

The amount you pay for Verzenio is influenced by several factors:

Insurance Coverage: Most commercial insurance plans and Medicare Part D cover Verzenio. However, your individual copay, coinsurance, or deductible will determine your final out-of-pocket expense.
Specialty Pharmacies: Verzenio is a specialty medication. It is often not available at local retail pharmacies and must be ordered through a specialty pharmacy provider.
Brand-Name Status: There is currently no generic version of Verzenio available. Brand-name medications typically cost more than generics.

Financial Support Options

If you are having difficulty affording your medication, there may be resources available to help:

Patient Assistance Programs: The manufacturer may offer programs to help eligible patients with the cost of the drug, including savings cards for those with commercial insurance.
Foundation Support: Some independent charitable foundations provide financial assistance to help patients pay for cancer treatments.

It is recommended to contact your insurance provider or the specialty pharmacy to get an accurate estimate of your costs before starting treatment.

Verzenio

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Verzenio

Hospitals.net Disclosure